NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $372,000 | -12.7% | 4,546 | -2.7% | 0.02% | -13.8% |
| Q2 2021 | $426,000 | +6.0% | 4,674 | -0.6% | 0.03% | 0.0% |
| Q1 2021 | $402,000 | -8.4% | 4,702 | +1.2% | 0.03% | -14.7% |
| Q4 2020 | $439,000 | +15.5% | 4,647 | +2.8% | 0.03% | +3.0% |
| Q3 2020 | $380,000 | -11.8% | 4,522 | -8.3% | 0.03% | -19.5% |
| Q2 2020 | $431,000 | +6.2% | 4,930 | +0.2% | 0.04% | -12.8% |
| Q1 2020 | $406,000 | -22.2% | 4,920 | -10.7% | 0.05% | -4.1% |
| Q4 2019 | $522,000 | +8.3% | 5,511 | -0.6% | 0.05% | -3.9% |
| Q3 2019 | $482,000 | -14.8% | 5,547 | -10.5% | 0.05% | -13.6% |
| Q2 2019 | $566,000 | -4.2% | 6,196 | +0.8% | 0.06% | -7.8% |
| Q1 2019 | $591,000 | -7.2% | 6,149 | -17.2% | 0.06% | -19.0% |
| Q4 2018 | $637,000 | – | 7,427 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |